In patients with ERα negative tumors the RFS rate did not show a significant association to ISG12 expression levels (Figure 8C) suggesting that the effect of ISG12 on RFS in breast cancer patients depends on the expression of ERα. The gene discussed is ESR1; the disease is breast carcinoma.